xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

453

ICAR SINONASAL TUMORS

adjuvant chemoradiation. Int J Clin Rhinol . 2012;5(3):118-122. https://doi.org/10.5005/jp-journals-10013-1131 2044. Peng G, Ke Y, Wang T, Feng Y, Li Y, Wu G. Intensity modulated radiotherapy for sinonasal teratocarcinosarcoma. J Huazhong Univ Sci Technolog Med Sci . 2011;31(6):857-860. https://doi.org/10.1007/s11596-011-0691-x 2045. Kane SV, Karpate AA, Bal M, Juvekar SL, Pai PS. Chemotherapy-induced neuronal maturation in sinonasal teratocarcinosarcoma—a unique observation. Head Neck Pathol . 2009;3(1):31-36. https://doi.org/10.1007/s12105-008 0094-x 2046. Nitsche M, Hermann RM, Christiansen H, Berger J, Pradier O. Rationale for individualized therapy in Sinonasal Teratocar cinosarcoma (SNTC): case report. Onkologie . 2005;28(12):653 656. https://doi.org/10.1159/000089146 2047. Liu JK, Eloy JA. Modified one-piece extended transbasal approach for resection of giant anterior skull base sinonasal teratocarcinosarcoma. Neurosurg Focus . 2012;32(Suppl. 1):E4. https://doi.org/10.3171/2012.V4.FOCUS11301 2048. Belotti A, Carpenito L, Bulfamante AM, Maccari A, Bulfamante G. Sinonasal teratocarcinosarcoma treated with surgery and proton beam therapy: clinical, histological aspects and differential diagnosis of a new case. Pathologica . 2021;113(06):469-474. https://doi.org/10.32074/1591-951X-215 2049. de Lotbinière-Bassett M, Avery MB, Starreveld YP. A unique case of sinonasal teratocarcinosarcoma presenting as Fos ter Kennedy Syndrome. Can J Neurol Sci . 2019;46(3):366-368. https://doi.org/10.1017/cjn.2019.33 2050. Bhalla V, Chowdhury N, Alvi S, Chamoun R, Beahm D. Two cases of sinonasal teratocarcinosarcoma: confounders, treat ment, and review of the literature. J Neurol Surg B . 2016;77(S 01):s-0036-1579996. https://doi.org/10.1055/s-0036-1579996 2051. Rashid T, Baig S, Saeed I, Mahasin Z. Sinonasal teratocar cinosarcoma: management and literature review. Pak JMed HealthSci . 2012;6:7924. 2052. McKean E, Burgin S, Sullivan S, Nor J, Brenner C. Targetable pathway genome sequencing for a sinonasal teratocarcinosar coma and xenograft chemotherapeutic testing for personal ized medicine. J Neurol Surg B . 2014;75(S 01):s-0034-1370602. https://doi.org/10.1055/s-0034-1370602 2053. Minasi S, De Vincentiis L, D’Ecclesia A, Corsi A, Giangaspero F. Pathogenetic analysis of sinonasal teratocarcinosarcomas reveal actionable β -catenin overexpression and a β -catenin mutation. J Neurol Surg B Skull Base . 2021;82(Suppl. 3):e112 e113. https://doi.org/10.1055/s-0039-3400228 2054. Dodhia S, Fitzgerald CWR, McLean AT, et al. Predictors of surgical complications in patients with sinonasal malignancy. J Surg Oncol . 2021;124(5):731-739. https://doi.org/10.1002/jso. 26598 2055. Overdevest JB, Amans MR, Zaki P, Pletcher SD, El-Sayed IH. Patterns of vascularization and surgical morbidity in juve nile nasopharyngeal angiofibroma: a case series, systematic review, and meta-analysis. Head Neck . 2018;40(2):428-443. https://doi.org/10.1002/hed.24987 2056. Ganly I, Patel SG, Singh B, et al. Complications of craniofacial resection for malignant tumors of the skull base: report of an International Collaborative Study. HeadNeck . 2005;27(6):445 451. https://doi.org/10.1002/hed.20166

2028. Yang Z, Uppaluri R, Lewis JS. Ethmoid sinus mass. Sinonasal teratocarcinosarcoma. JAMA Otolaryngol Head Neck Surg . 2015;141(4):389-390. https://doi.org/10.1001/jamaoto.2015.22 2029. Szudek J, Bullock M, Taylor SM. Sinonasal teratocarci nosarcoma involving the cavernous sinus. J Otolaryngol . 2005;34(4):286-288. https://doi.org/10.2310/7070.2005.34421 2030. Sharma HS, Abdullah JM, Othman NH, Muhamad M. Teratocarcinosarcoma of the nasal cavity and ethmoid. J Laryngol Otol . 1998;112(7):682-686. https://doi.org/10.1017/ s0022215100141453 2031. Joko H. A case of teratocarcinosarcoma in nasal septum. Otolaryngol Head Neck Surg . 1997;69:560-564. 2032. Wahid FI, Javaid M, Khan Q, Khan IA. Sinonasal teratocarci nosarcoma. J Coll Physicians Surg Pak . 2012;22(5):335-337. 2033. Sakci Z, Aydin F, Ceylan O, Ogul H. Sinonasal teratocar cinosarcoma mimicking chronic invasive fungal disease of paranasal sinuses. Annals . 2021;103(6):e193-e195. https://doi. org/10.1308/rcsann.2020.7088 2034. Rao Y-f, Cheng D-n, Qiu K, et al. Sinonasal teratocar cinosarcoma: a case report and literature review. J Int Med Res . 2020;48(12):030006052097148. https://doi.org/10. 1177/0300060520971488 2035. Foong YC, Murdolo V, Naiman N, Hepner L, Awad R. Sinonasal teratocarcinosarcoma: a case report. J Med Case Reports . 2017;11(1):167. https://doi.org/10.1186/s13256-017 1327-y 2036. Sable M, Kakkar A, Garg K, Suri V. Sinonasal teratocar cinosarcoma: an underdiagnosed entity posing diagnostic challenges. Turk Neurosurg . 2017;27(3):468-471. https://doi. org/10.5137/1019-5149.JTN.13092-14.1 2037. Kurmi D, Mittal R, Sharma A, Gandhi A, Singhvi S. Sinonasal teratocarcinosarcoma involving nasal cavity, nasopharynx, and all paranasal sinuses with bilateral orbital and intracra nial extension: a rare case report. Asian J Neurosurg . 2017;12(02):232-240. https://doi.org/10.4103/1793-5482.145559 2038. Joshi A, Noronha V, Sharma M, et al. Neoadjuvant chemotherapy in advanced sinonasal teratocarcinosar coma with intracranial extension: report of two cases with literature review. J Cancer Res Ther . 2015;11(4):1003-1005. https://doi.org/10.4103/0973-1482.165878 2039. Fukuoka K, Hirokawa M, Shimizu M, et al. Teratocarci nosarcoma of the nasal cavity. Report of a case showing favorable prognosis. APMIS . 2000;108(9):553-557. https://doi. org/10.1034/j.1600-0463.2000.d01-96.x 2040. Rooper LM, Uddin N, Gagan J, et al. Recurrent loss of SMARCA4 in sinonasal teratocarcinosarcoma. Am J Surg Pathol . 2020;44(10):1331-1339. https://doi.org/10.1097/ PAS.0000000000001508 2041. Belardinilli F, De Vincentiis L, D’Ecclesia A, Giannini G, Giangaspero F, Corsi A. PIK3CA somatic mutation in sinonasal teratocarcinosarcoma. Auris Nasus Larynx . 2021;48(3):530-534. https://doi.org/10.1016/j.anl.2020.03.006 2042. Compton ML, Lewis JS, Faquin WC, Cipriani NA, Shi Q, Ely KA. SALL-4 and beta-catenin expression in sinonasal terato carcinosarcoma. Head Neck Pathol . 2022;16(1):229-235. https:// doi.org/10.1007/s12105-021-01343-3 2043. Gupta S, Naik S, Lnu N, et al. Sinonasal teratocarcinosarcoma: a rare clinical entity managed by medial maxillectomy and